Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC, explain how Mayo Clinic Laboratories' gene panel establishes a diagnosis of Lynch syndrome, which heightens the risk for several cancers. Test results can guide cancer surveillance for patients and their families.
(
00:32)
Would each of you share a little bit about yourselves and your background? Dr. Shen?
(
01:25)
Rihanna, could we have you give a little background about yourself as well?
(
01:48)
Could you provide us with an overview of Lynch syndrome?
(
03:44)
Can you expand on why genetic testing for Lynch syndrome is so important?
(
06:03)
Who would benefit from Lynch testing?
(
07:51)
Is Lynch syndrome the only type of inherited predisposition to colon cancer?
(
08:48)
Does the healthcare provider order these tests, and what kind of samples should be considered in these patients?
(
10:50)
Are there any limitations to the types of variants that can be detected by this test? And how does Mayo Clinic Laboratories ensure comprehensive results for patients?
(
14:24)
How are the results used in patient care?
(
16:33)
Could you summarize the benefits of these tests and of doing them at Mayo Clinic Laboratories?